Neuraxis
NRXS
9 hedge funds and large institutions have $790K invested in Neuraxis in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
156% more capital invested
Capital invested by funds: $308K → $790K (+$481K)
2.07% more ownership
Funds ownership: 1.67% → 3.73% (+2.1%)
10% less funds holding
Funds holding: 10 → 9 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$451K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$31.3K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.93K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$24 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$37.7K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.88K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$723 |
NRXS Hedge Fund Activity: Q3 2024 in Review
9 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Neuraxis (NRXS) for Q3 2024, worth a combined $790K — up 156% from $308K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of NRXS and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 3 added.
The largest buyer was Bank of Montreal, opening a new position worth an estimated $451K. The largest seller was Citadel Advisors, exiting entirely with an estimated $37.7K sold.
- 9 institutional investors held Neuraxis (NRXS) as of Q3 2024, down from 10 in Q2 2024.
- Funds reported $790K of Neuraxis stock for Q3 2024, up 156% quarter-over-quarter.
- 1 fund opened new Neuraxis positions in Q3 2024 and 2 closed out, a net change of -1 holder.
- The largest Neuraxis buyer in Q3 2024 was Bank of Montreal, an estimated $451K added.
- The largest Neuraxis seller in Q3 2024 was Citadel Advisors, an estimated $37.7K sold.
Based on aggregated 13F filings for Q3 2024.